Xyrem®

DRUG3 trials

Sponsors

Jazz Pharmaceuticals

Conditions

Fibromyalgia

Phase 3

A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia

CompletedNCT00371137

Jazz PharmaceuticalsFibromyalgia

Start: 2006-08-31End: 2008-12-31Updated: 2011-12-29

A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

CompletedNCT00423813

Jazz PharmaceuticalsFibromyalgia

Start: 2006-12-31End: 2009-06-30Updated: 2012-01-24

Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.

CompletedNCT00423605

Jazz PharmaceuticalsFibromyalgia

Start: 2006-12-31End: 2010-01-31Updated: 2012-03-30

Related Papers

Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia.

2013-11-1111 citations